Back to Journals » Clinical Interventions in Aging » Volume 14

Could Teriparatide Replace Percutaneous Vertebral Augmentation for Patients with Osteoporotic Vertebral Compression Fracture to Some Extent? [Letter]

Authors Zhou J, Xue Y

Received 14 October 2019

Accepted for publication 25 November 2019

Published 2 December 2019 Volume 2019:14 Pages 2095—2096

DOI https://doi.org/10.2147/CIA.S234553

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Nicola Ludin

Peer reviewer comments 2

Editor who approved publication: Dr Zhi-Ying Wu


Jiaming Zhou, Yuan Xue

Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China

Correspondence: Yuan Xue
Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China
Tel +86 22 60814688
Fax +86 22 27219052
Email xueyuanzyy@163.com


We read with great interest the article by Kong et al.1 In their study, the authors found that for patients with osteoporotic vertebral compression fracture (OVCF), treatment with percutaneous kyphoplasty (PKP) and teriparatide showed a lower risk of new vertebral compression fracture (NVCF) and better clinical outcomes than with PKP and basic treatment (calcium and vitamin D). We wish to express our opinion on this topic.


View the original paper by Kong and colleagues
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]